New pathways in the treatment for menopausal hot flushes
- PMID: 28385351
- DOI: 10.1016/S0140-6736(17)30886-3
New pathways in the treatment for menopausal hot flushes
Comment on
-
Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: a phase 2, randomised, double-blind, placebo-controlled trial.Lancet. 2017 May 6;389(10081):1809-1820. doi: 10.1016/S0140-6736(17)30823-1. Epub 2017 Apr 3. Lancet. 2017. PMID: 28385352 Free PMC article. Clinical Trial.
Similar articles
-
First time proof of sage's tolerability and efficacy in menopausal women with hot flushes.Adv Ther. 2011 Jun;28(6):490-500. doi: 10.1007/s12325-011-0027-z. Epub 2011 May 16. Adv Ther. 2011. PMID: 21630133 Clinical Trial.
-
Endothelial function, but not carotid intima-media thickness, is affected early in menopause and is associated with severity of hot flushes.J Clin Endocrinol Metab. 2010 Mar;95(3):1199-206. doi: 10.1210/jc.2009-2262. Epub 2010 Jan 15. J Clin Endocrinol Metab. 2010. PMID: 20080857
-
[Influence of the presence of hot flashes during menopause on the metabolism of nitric oxide. Effects of hormonal replacement treatment].Med Clin (Barc). 2000 Jan 22;114(2):41-5. Med Clin (Barc). 2000. PMID: 10702946 Spanish.
-
Managing Hot Flushes in Menopausal Women: A Review.J Coll Physicians Surg Pak. 2018 Jun;28(6):460-465. doi: 10.29271/jcpsp.2018.06.460. J Coll Physicians Surg Pak. 2018. PMID: 29848424 Review.
-
Neurokinin 3 receptor antagonism - the magic bullet for hot flushes?Climacteric. 2017 Dec;20(6):505-509. doi: 10.1080/13697137.2017.1385598. Epub 2017 Oct 17. Climacteric. 2017. PMID: 29040006 Review.
Cited by
-
Novel Evidence-Based Combination of Plant Extracts with Multitarget Mechanisms of Action for the Elimination of Hot Flashes during Menopause.Molecules. 2022 Feb 11;27(4):1221. doi: 10.3390/molecules27041221. Molecules. 2022. PMID: 35209016 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
